Gabapentin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
An anticonvulsant and analgesic used for the treatment of postherpetic neuralgia and as adjunctive therapy for partial seizures. Gabapentin is widely used off-label for various neuropathic pain conditions, including diabetic peripheral neuropathy, fibromyalgia, and chronic pain syndromes. It is a first-line treatment for neuropathic pain per multiple guidelines.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
An anticonvulsant and analgesic used for the treatment of postherpetic neuralgia and as adjunctive therapy for partial seizures. NutriStack rates the supporting evidence as strong. Common adult dosing is Start 300 mg on day 1, 300 mg twice daily on day 2, 300 mg three times daily on day 3; titrate up to 1800–3600 mg/day in 3 divided doses (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: treatment of postherpetic neuralgia, adjunctive therapy for partial seizures, off-label: diabetic peripheral neuropathy. 10 sources indexed (2019–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing calcium influx at nerve terminals. This decreases the release of excitatory neurotransmitters (glutamate, norepinephrine, substance P) involved in pain signaling and seizure propagation. Despite its name, gabapentin does not bind to GABA receptors or affect GABA uptake or metabolism.
Dosing & protocol.
Can be taken with or without food; bioavailability decreases at higher doses due to saturable absorption (L-amino acid transport system)6
Full safety detail.
Side effects
- Dizziness
- Somnolence
- Peripheral edema
- Ataxia and gait disturbance
- Fatigue
- Weight gain
- Blurred vision
- Cognitive impairment (difficulty concentrating)
Contraindications
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Cardiovascular safety of gabapentinoids gabapentin & pregabalin: A systematic reviewPMIDDutta D, Mohindra R, Kumar M et al. · The Indian journal of medical research · 2025
Dutta D, Mohindra R, Kumar M et al.. Cardiovascular safety of gabapentinoids gabapentin & pregabalin: A systematic review. The Indian journal of medical research. 2025
- 2Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safetyPMIDMayoral V, Galvez R, Ferrándiz M et al. · Frontiers in pain research (Lausanne, Switzerland) · 2024
Mayoral V, Galvez R, Ferrándiz M et al.. Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety. Frontiers in pain research (Lausanne, Switzerland). 2024
- 3Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled TrialsPMIDHuerta MÁ, Garcia MM, García-Parra B et al. · International journal of molecular sciences · 2023
Huerta MÁ, Garcia MM, García-Parra B et al.. Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials. International journal of molecular sciences. 2023
- 4A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica painPMIDGiménez-Campos MS, Pimenta-Fermisson-Ramos P, Díaz-Cambronero JI et al. · Atencion primaria · 2022
Giménez-Campos MS, Pimenta-Fermisson-Ramos P, Díaz-Cambronero JI et al.. A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain. Atencion primaria. 2022
- 5Gabapentin for uremic pruritus: a systematic review of randomized controlled trialsPMIDEusebio-Alpapara KMV, Castillo RL, Dofitas BL · International journal of dermatology · 2020
Eusebio-Alpapara KMV, Castillo RL, Dofitas BL. Gabapentin for uremic pruritus: a systematic review of randomized controlled trials. International journal of dermatology. 2020
- 6A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder.PMIDKranzler HR, Feinn R, Morris P et al. · Addiction · 2019
Meta-analysis of RCTs found gabapentin significantly reduced heavy drinking days and increased abstinence rates compared to placebo in alcohol use disorder, with effects most pronounced at higher doses (≥1800 mg/day).
Reference material
4- 7Wiffen PJ et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017.Source linkedPMID
- 8Finnerup NB et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015.Source linkedPMID
- 9Backonja M et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA. 1998.Source linkedPMID
- 10Hong JSW, Atkinson LZ, Al-Juffali N et al.. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Molecular psychiatry. 2022Source linkedPMID
Common questions.
Quick answers about Gabapentin, drawn from the data on this page.
What is Gabapentin?
An anticonvulsant and analgesic used for the treatment of postherpetic neuralgia and as adjunctive therapy for partial seizures. Gabapentin is widely used off-label for various neuropathic pain conditions, including diabetic peripheral neuropathy, fibromyalgia, and chronic pain syndromes. It is a first-line treatment for neuropathic pain per multiple guidelines.
What is Gabapentin used for?
Commonly cited benefits of Gabapentin include: Treatment of postherpetic neuralgia; Adjunctive therapy for partial seizures; Off-label: diabetic peripheral neuropathy; Off-label: fibromyalgia pain; May improve sleep quality in neuropathic pain patients. NutriStack rates the overall evidence as strong.
What is a typical dose of Gabapentin?
A typical adult dose of Gabapentin is Start 300 mg on day 1, 300 mg twice daily on day 2, 300 mg three times daily on day 3; titrate up to 1800–3600 mg/day in 3 divided doses (as prescribed by your physician). The commonly recommended form is Capsule, tablet, or oral solution. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Gabapentin?
Reported side effects include dizziness, somnolence, peripheral edema, ataxia and gait disturbance, fatigue, weight gain. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Gabapentin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Gabapentin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.